Moses Makunje - 29 Feb 2024 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Role
Title: VP, Finance and principal financial and accounting officer.
Signature
/s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
NUVB
Transactions as of
29 Feb 2024
Net transactions value
$0
Form type
4
Filing time
04 Mar 2024, 17:22:05 UTC
Previous filing
27 Nov 2023
Next filing
04 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUVB Class A Common Stock Award $0 +250,000 $0.000000 250,000 29 Feb 2024 Class A Common Stock 250,000 $1.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.

Remarks:

Title: VP, Finance and principal financial and accounting officer.